Fig. 3
From: Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
Serum CPT1A level in different clinicopathological classifications of breast cancer. a Serum CPT1A levels from non-metastatic and metastatic breast cancer patients. b Serum CPT1A levels from breast cancer patients with different TNM stage. c Serum CPT1A levels from breast cancer patients with different histological grade. d Serum CPT1A levels from breast cancer patients of different molecular subtype. Statistical significance was were determined by the Mann–Whitney U test. *p < 0.05, **p < 0.001, ***p < 0.0001